Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danny Liew

Showing results (471-480 of 481) with videos related to

Pageof 49
Sort By:
Journal of Gastroenterology and Hepatology|December 16, 2016
Serologic antibodies in relation to outcome in postoperative Crohn's diseaseAmy L Hamilton, Michael A Kamm, Peter De Cruz, et al.
The Lancet. Gastroenterology & Hepatology|September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trialMatthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
Lancet (London, England)|December 28, 2014
Crohn's disease management after intestinal resection: a randomised trialPeter De Cruz, Michael A Kamm, Amy L Hamilton, et al.
JMIR AI|December 19, 2025
Predicting the Emergency Department Patient Journey Using a Machine Learning ApproachJoshua George Kovoor, Gavin John Carmichael, Brandon Stretton, et al.
Annals of Clinical and Translational Neurology|May 23, 2015
Predictors of disability worsening in clinically isolated syndromeVilija G Jokubaitis, Tim Spelman, Tomas Kalincik, et al.
Journal of Crohn'S & Colitis|April 10, 2015
Effect of intestinal resection on quality of life in Crohn's diseaseEmily K Wright, Michael A Kamm, Peter De Cruz, et al.
Cancer Discovery|December 7, 2018
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast CancerSheau W Lok, James R Whittle, François Vaillant, et al.
Gastroenterology|January 27, 2015
Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgeryEmily K Wright, Michael A Kamm, Peter De Cruz, et al.
Gastroenterology|July 23, 2025
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UCChristopher F D Li Wai Suen, Matthew C Choy, Danny Con, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2014
Risk of relapse phenotype recurrence in multiple sclerosisTomas Kalincik, Katherine Buzzard, Vilija Jokubaitis, et al.
Pageof 49

Showing results (471-480 of 481) with videos related to

Sort By:
Pageof 49
Journal of Gastroenterology and Hepatology|December 16, 2016
Serologic antibodies in relation to outcome in postoperative Crohn's diseaseAmy L Hamilton, Michael A Kamm, Peter De Cruz, et al.
The Lancet. Gastroenterology & Hepatology|September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trialMatthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
Lancet (London, England)|December 28, 2014
Crohn's disease management after intestinal resection: a randomised trialPeter De Cruz, Michael A Kamm, Amy L Hamilton, et al.
JMIR AI|December 19, 2025
Predicting the Emergency Department Patient Journey Using a Machine Learning ApproachJoshua George Kovoor, Gavin John Carmichael, Brandon Stretton, et al.
Annals of Clinical and Translational Neurology|May 23, 2015
Predictors of disability worsening in clinically isolated syndromeVilija G Jokubaitis, Tim Spelman, Tomas Kalincik, et al.
Journal of Crohn'S & Colitis|April 10, 2015
Effect of intestinal resection on quality of life in Crohn's diseaseEmily K Wright, Michael A Kamm, Peter De Cruz, et al.
Cancer Discovery|December 7, 2018
A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2-Positive Metastatic Breast CancerSheau W Lok, James R Whittle, François Vaillant, et al.
Gastroenterology|January 27, 2015
Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgeryEmily K Wright, Michael A Kamm, Peter De Cruz, et al.
Gastroenterology|July 23, 2025
Early Infliximab Levels and Clearance Predict Outcomes After Infliximab Rescue in Acute Severe Ulcerative Colitis: Results From PREDICT-UCChristopher F D Li Wai Suen, Matthew C Choy, Danny Con, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 30, 2014
Risk of relapse phenotype recurrence in multiple sclerosisTomas Kalincik, Katherine Buzzard, Vilija Jokubaitis, et al.
Pageof 49